[Close]
This page was created by volunteers like you!
Help us make it even better. To learn more about contributing to MEpedia, click here.
Join the movement
Visit #MEAction to find support or take action. Donate today to help us improve and expand this project.
Congratulations!
MEpedia has got over 30 million views as of August 2022!

Nigella sativa

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history

Nigella sativa or black seed is a herb with antioxidant and anti-inflammatory properties.[1][2] The active ingredient in nigella sativa is thymoquinone, and it has been investigated for a wide range of medical conditions.[1][3]

Theory[edit | edit source]

Evidence[edit | edit source]

Clinicians[edit | edit source]

Risks and safety[edit | edit source]

Costs and availability[edit | edit source]

Notable studies[edit | edit source]

  • 2015, Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review[4] (Abstract)
  • 2015, Effect of vitamins C, E and nigella sativa seeds on antioxidant activity in fibromyalgia patients[5] (Full text)
  • 2015, Effect of Nigella Sativa and Vitamin E on Some Oxidative / Nitrosative Biomarkers in Systemic Lupus Erythematosus Patients[6] (Full text)
  • 2016, Neuropharmacological effects of Nigella sativa[7] (Full text)
  • 2017, Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone[3] (Full text)
  • 2020, Nigella sativa: Valuable perspective in the management of chronic diseases[2] (Full text)

See also[edit | edit source]

Learn more[edit | edit source]

References[edit | edit source]

  1. ↑ Jump up to: 1.0 1.1 "Nigella sativa". Memorial Sloan Kettering Cancer Center. Retrieved December 21, 2021.
  2. ↑ Jump up to: 2.0 2.1 Pop, Raluca Maria; Trifa, Adrian Pavel; Popolo, Ada; Chedea, Veronica Sanda; Militaru, Claudia; Bocsan, Ioana Corina; Buzoianu, Anca Dana (June 2020). "Nigella sativa: Valuable perspective in the management of chronic diseases". Iranian Journal of Basic Medical Sciences. 23 (6): 699–713. doi:10.22038/ijbms.2020.37734.8978. ISSN 2008-3866. PMC 7351440. PMID 32695285.
  3. ↑ Jump up to: 3.0 3.1 Tavakkoli, Alireza; Mahdian, Vahid; Razavi, Bibi Marjan; Hosseinzadeh, Hossein (September 2017). "Review on Clinical Trials of Black Seed (Nigella sativa ) and Its Active Constituent, Thymoquinone". Journal of Pharmacopuncture. 20 (3): 179–193. doi:10.3831/KPI.2017.20.021. ISSN 2093-6966. PMC 5633670. PMID 30087794.
  4. ↑ Majdalawieh, Amin F.; Fayyad, Muneera W. (September 2015). "Immunomodulatory and anti-inflammatory action of Nigella sativa and thymoquinone: A comprehensive review". International Immunopharmacology. 28 (1): 295–304. doi:10.1016/j.intimp.2015.06.023. ISSN 1878-1705. PMID 26117430.
  5. ↑ Iqbal R, Mughal MS, Asghar MN, Shaheen N, Ahmad NM, Farman S, Saeed MA, Khan IU, Arshad M (2015). "Effect of Vitamins C, E and Nigella sativa Seeds on Antioxidant Activity in Fibromyalgia Patients" (PDF). Pakistan J. Zool. 47 (1): 7–13.
  6. ↑ http://www.lifesciencesite.com/lsj/life120715/016_29075life120715_157_162.pdf
  7. ↑ Beheshti, Farimah; Khazaei, Majid; Hosseini, Mahmoud (2016). "Neuropharmacological effects of Nigella sativa". Avicenna Journal of Phytomedicine. 6 (1): 104–116. ISSN 2228-7930. PMC 4884225. PMID 27247928.

immunomodulator An immunomodulator is a substance that affects the functioning of the immune system

chronic disease a disease or condition that usually lasts for 3 months or longer and may get worse over time. Chronic diseases are long-term (typically incurable and requiring long-term management) but are not necessarily severe.

Retrieved from "https://me-pedia.org/w/index.php?title=Nigella_sativa&oldid=241459"